ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
AHR-Responsive Carbon Dots Orchestrate Skin Wound Healing and Colonic Mucosal Repair via Treg-Mediated Macrophage Efferocytosis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
As critical interface organs, the gut and skin share substantial immunological similarities, and gut diseases are often accompanied by skin comorbidities, yet the underlying mechanisms remain unclear. Here, we observed delayed skin wound healing in a mouse model of colitis. To promote both skin and intestinal repair, we designed aryl hydrocarbon receptor (AHR)-responsive carbon dots using pharmacophore modeling and fragment-based drug design. These nanoscale carbon dots significantly alleviated colitis and accelerated impaired skin wound healing. The carbon dots preferentially accumulated in the inflamed colon, where they induced infiltration of tissue-resident regulatory T (Treg) cells, thereby suppressing mucosal inflammation and promoting tissue repair. Mechanistically, the carbon dots activated AHR signaling to drive Treg cell differentiation. Importantly, Treg-derived chemokine CCL1 enhanced macrophage efferocytosis, establishing a pro-regenerative immune microenvironment in both the colon and skin wounds via STAT3-SCARB1 signaling. Notably, Ccl1 knockdown attenuated the therapeutic effects of carbon dots on both colonic mucosal repair and skin wound healing, supporting CCL1 as a key mediator of gut-skin immune communication. Collectively, this study highlights the important role of Treg cells in gut-skin axis crosstalk and provides a nanomaterial-based strategy for coordinated tissue repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.